Medical Xpress news

Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths—around 1.8 million lives lost each year. One of the main reasons is late diagnosis: in its early stages, ...

As many as 1 in 4 cancers are driven by mutations in the SWI/SNF chromatin-remodeling complex, which controls access to DNA. A study led by St. Jude Children's Research Hospital recently identified the gene-regulatory protein ...

The tumor begins before birth. Somewhere in the developing fetus, neural crest cells that should have matured into adrenal tissue or sympathetic ganglia take a wrong turn, and a child is born harboring a malignancy that may ...

A Georgia State University study shows standard cognitive screening tools used to monitor Alzheimer's disease may not reflect underlying brain changes in the same way for women and men. According to the Alzheimer's Association, ...

University of Virginia School of Medicine researchers have used an advanced gene-editing technique to correct the underlying cause of a severe form of epilepsy in lab mice. This breakthrough could one day lead to new treatments ...

People whose sleep apnea changes dramatically from night to night are 30% more likely to have a heart attack, stroke, or heart failure, reveals a new study from Flinders University. The research, published in the journal ...

A major new global modeling study led by researchers at Stockholm Environment Institute (SEI) at the University of York challenges the international focus on air pollution. Published in The Lancet Planetary Health, the study ...

Psychotherapy has always been a deeply human endeavor: a patient talking, a therapist listening and responding, and healing happening through words. But with the rapid rise of conversational artificial intelligence, particularly ...

Originally developed to treat diabetes, a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are now stepping into the spotlight as weight loss drugs. A recent umbrella review draws attention to ...

UCLA scientists have developed a simple and cost-effective blood test that, in early studies, shows promise in detecting multiple cancers, various liver conditions and organ abnormalities simultaneously by analyzing DNA fragments ...

Scripps Research scientists have developed a new class of drug compounds that reduce harmful inflammation while leaving the body's ability to fight infections intact—a long-sought goal in treating autoimmune diseases. The ...

Psychedelic drugs are being investigated as scientific and clinical tools, but the brain mechanisms behind their effects remain unclear. Earlier brain imaging studies in small cohorts from single centers produced inconsistent ...